Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.11 USD | -1.58% |
|
-1.89% | -15.72% |
06-28 | CSPC Pharmaceutical Group Limited Announces Enlonstobart Injection Obtains Conditional Marketing Approval | CI |
06-28 | CSPC Pharma's Breast Cancer Drug Gets Approval in China | MT |
Evolution of the average Target Price on CSPC Pharmaceutical Group Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering CSPC Pharmaceutical Group Limited
Nomura | |
UBS |
EPS Revisions
- Stock Market
- Equities
- 1093 Stock
- CSPCY Stock
- Consensus CSPC Pharmaceutical Group Limited